Magenta Therapeutics, Inc.
Linkers for antibody-drug conjugates and related compounds, compositions, and methods of use

Last updated:

Abstract:

Provided herein are antibody-cytotoxin antibody-drug conjugates and related compounds, such as linker-cytotoxin conjugates and the linkers used to make them, and intermediates in their synthesis; compositions; and methods, including methods of treating cancers.

Status:
Grant
Type:

Utility

Filling date:

6 Jun 2014

Issue date:

25 Jan 2022